Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATReceivables - Net
Ratios

Alaunos Therapeutics (TCRT) Shares Repurchased (2016 - 2018)

Alaunos Therapeutics (TCRT) has disclosed Shares Repurchased for 8 consecutive years, with $347000.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Shares Repurchased rose 133.3% year-over-year to $347000.0, compared with a TTM value of $347000.0 through Dec 2022, changed 0.0%, and an annual FY2022 reading of $45000.0, changed N/A over the prior year.
  • Shares Repurchased was $347000.0 for Q4 2018 at Alaunos Therapeutics, down from $544000.0 in the prior quarter.
  • Across five years, Shares Repurchased topped out at $851000.0 in Q2 2016 and bottomed at -$1.0 million in Q4 2017.
  • Average Shares Repurchased over 5 years is $96666.7, with a median of $189500.0 recorded in 2015.
  • The sharpest move saw Shares Repurchased crashed 183.74% in 2015, then soared 133.3% in 2018.
  • Year by year, Shares Repurchased stood at $412000.0 in 2014, then plummeted by 183.74% to -$345000.0 in 2015, then tumbled by 146.67% to -$851000.0 in 2016, then dropped by 22.44% to -$1.0 million in 2017, then skyrocketed by 133.3% to $347000.0 in 2018.
  • Business Quant data shows Shares Repurchased for TCRT at $347000.0 in Q4 2018, $544000.0 in Q2 2018, and $731000.0 in Q1 2018.